Effects of Epstein-Barr virus viral load and different treatment modality for stage III nasopharyngeal carcinoma.

Chih-Wen TwuWen-Yi WangHsiao-Hui TsouYi-Chun LiuRong-San JiangKai-Li LiangPo-Ju LinTian-Yun LinHsin-Hong ChenJin-Ching Lin

Published in: Head & neck (2020)

Long-term treatment results for stage III NPC patients are rather good. IndCT-RT can achieve the same treatment outcome as CCRT. Risk grouping by pretreatment viral load identified a subgroup (30%) of patients associated with a significantly higher relapse rates and worse survivals. These high-risk patients need to strengthen treatment intensity in future trials.

Keyphrases

end stage renal disease
ejection fraction
prognostic factors
peritoneal dialysis
randomized controlled trial
combination therapy
patient reported
study protocol
current status